Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma (Oncogene, (2011), 30, 25, (2823-2835), 10.1038/onc.2011.10)

G. Fiaschetti, D. Castelletti, S. Zoller, A. Schramm, C. Schroeder, M. Nagaishi, D. Stearns, M. Mittelbronn, A. Eggert, F. Westermann, H. Ohgaki, T. Shalaby, M. Pruschy, A. Arcaro, M. A. Grotzer*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Following publication of this article, the authors noted Figure 1b incorrectly reported beta-tubulin as the control used for the western blot analysis when beta-actin was used. In addition, in this figure, the control bands of DAOY cells M2.1 and M14 were inadvertently swapped. The corrected figure is shown below. The authors apologise for the inconvenience caused and confirm this does not have any impact on the interpretation of the results. The original article has been corrected.

Original languageEnglish
Pages (from-to)168
Number of pages1
JournalOncogene
Volume42
Issue number2
Early online date7 Dec 2022
DOIs
Publication statusPublished - Jan 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma (Oncogene, (2011), 30, 25, (2823-2835), 10.1038/onc.2011.10)'. Together they form a unique fingerprint.

Cite this